Overview
Geeta Swamy, MD, Haywood Brown, MD Distinguished Professor of Women’s Health, serves as Executive Vice Dean for Clinical Sciences & Research Administration for the Duke University School of Medicine and Associate Vice President for Research for Duke University. In these roles, Dr. Swamy oversees central operations aligned with clinical departments and research centers, facilitating research priorities in collaboration with clinical chairs and vice chairs, and managing research administration and compliance. She works closely with leadership across the Duke Health Integrated Practice (DHIP) and Duke University Health System (DUHS) on areas that intersect with the academic missions. She collaborates with leaders across the Duke University campus to provide a consistent vision for research administration, operations, quality, and accountability. Her responsibilities include overseeing pre- and post-award management for sponsored grants and contracts, human research, research quality, compliance, and integrity, conflict of interest, and other regulatory areas. As a highly accomplished clinician-scientist, Dr. Swamy’s research specializes in perinatal infection, maternal immunization, and complications of pregnancy.
Current Appointments & Affiliations
Haywood Brown, MD Distinguished Professor of Women's Health
·
2022 - Present
Obstetrics and Gynecology, Maternal Fetal Medicine,
Obstetrics and Gynecology
Professor of Obstetrics and Gynecology
·
2021 - Present
Obstetrics and Gynecology, Maternal Fetal Medicine,
Obstetrics and Gynecology
Interim Chair, Department of Dermatology
·
2025 - Present
School of Medicine
Member of the Duke Human Vaccine Institute
·
2013 - Present
Duke Human Vaccine Institute,
Institutes and Centers
Recent Publications
Early Postnatal Polymerase Chain Reaction Testing in the Identification of Perinatal Transmission of Hepatitis C Virus.
Journal Article Clin Infect Dis · February 4, 2026 In this study, a single hepatitis C virus (HCV) RNA at 2-6 months was sensitive and specific (86.7% and 95% confidence interval [CI], 62.1%-96.3% and 100% and 95% CI, 98.8%-100%, respectively) in identifying perinatal transmission of HCV. No cases of perin ... Full text Link to item CiteChildhood Pulmonary Outcomes After Late Preterm Antenatal Corticosteroids.
Journal Article Obstet Gynecol · January 22, 2026 OBJECTIVE: To evaluate whether antenatal betamethasone affects childhood respiratory impairment. METHODS: This was a prospective follow-up study of children aged 6 years and older from parents in the ALPS (Antenatal Late Preterm Steroids) trial randomized ... Full text Link to item CiteAssessing the Association Between Perceived Discrimination in Health Care and Postpartum Contraception.
Journal Article J Womens Health (Larchmt) · December 11, 2025 Objectives: To assess the association between perceived discrimination in health care and postpartum contraceptive plans among a diverse group of postpartum individuals. Materials and Methods: This was a cross-sectional study of individuals postpartum prio ... Full text Link to item CiteRecent Grants
State reproductive health policy as a determinant for maternal health
ResearchCo Investigator · Awarded by National Institutes of Health · 2025 - 20302/3 CTSA K12 Program at Duke University
ResearchMentor · Awarded by National Institutes of Health · 2025 - 2030Duke Women's Reproductive Health Research Scholars
Inst. Training Prgm or CMEMentor · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2020 - 2030View All Grants
Education, Training & Certifications
University of North Carolina, Chapel Hill ·
1997
M.D.